Brief: PledPharma Updates On Pledox Phase I Study In Japan

Egetis Therapeutics AB (publ)

09/02/2018 06:34

Feb 9 (Reuters) - Pledpharma Ab (Publ)  PLED.ST : 
    * PLEDOX SHOWS FAVORABLE SAFETY AND TOLERABILITY PROFILE IN 
THE 
SUNCIST PHASE I STUDY IN JAPANESE SUBJECTS 
    * PLEDOX SHOWS FAVORABLE SAFETY AND TOLERABILITY PROFILE 
IN 
SUNCIST PHASE I STUDY IN JAPANESE SUBJECTS 
 
Source text for Eikon:  ID:nSSN7lq8  
Further company coverage:  PLED.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))